Michelle Capobianco
CEOFemale0.0Global Dominance: 0.00%
Michelle Capobianco is the chief executive officer of Pancreatic Cancer North America, advocating for improved detection and treatment options for pancreatic cancer, highlighting the need for significant advancements beyond temporary solutions like daraxonrasib.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Michelle Capobianco, CEO of Pancreatic Cancer North America, emphasized the need for early detection.
Drug that could extend lives of Canadians with pancreatic cancer remains out of reach for patientsThe Globe and Mail·
Canada· 2026-07-08
Canada· 2026-07-08
